Understand the source comparison
Best Peptides to Boost Immune System Ranked: Mechanism Comparison
Before selecting a peptide for immune modulation, understanding the specific immune pathway each targets prevents mismatches between mechanism and goal. The table below compares the three highest-evidence peptides across immune function, mechanism specificity,
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting a peptide for immune modulation, understanding the specific immune pathway each targets prevents mismatches between mechanism and goal. The table below compares the three highest-evidence peptides across immune function, mechanism specificity, published clinical data, optimal use case, and professional assessment.
- Thymalin
- Thymic stimulation. Increases CD4+ and CD8+ T-cell maturation via thymic epithelial receptor activation
- Randomised trials showing 28–34% increase in T-cell counts post-viral infection; improved NK cell cytotoxicity by 22%
- Lymphopenia, post-infection recovery, age-related thymic involution, chemotherapy-induced immunosuppression
- 10mg subcutaneous daily for 10 days, repeated monthly
- Strongest evidence for measurable T-cell restoration; requires consistent dosing schedule
- KPV
- NF-κB inhibition. Suppresses pro-inflammatory cytokine transcription (IL-1β, IL-6, TNF-α) without blocking pathogen recognition
- Clinical trial data showing 41% CRP reduction over 12 weeks; improved vaccine antibody response in high-inflammation subjects
- Chronic low-grade inflammation, autoimmune flares, post-viral inflammatory syndrome
- 500mcg subcutaneous 3× weekly as maintenance
- Most effective for inflammatory immune dysfunction; timing between infections critical
- BPC-157
- VEGF/FGF upregulation. Enhances tissue repair, angiogenesis, and immune cell trafficking through improved vascularisation
- Animal models showing 68% reduction in inflammatory tissue damage; improved lymphoid tissue cellularity
- Chronic wounds, gut barrier dysfunction, injury-associated inflammation, mucosal immunity support
- 250–500mcg subcutaneous daily near injury site or systemically
- Indirect immune benefit through tissue environment optimisation; pairs well with direct immune peptides